Office of Cancer Centers logo

FAQs | Site Map

  • Cancer Centers  
    • a Cancer Center
    • a Research Program
    • a Shared Resource
    • Skip to content
    • Benchmark Data
    • Data Table 1
    • Data Table 2
    • Data Table 3
    • Data Table 4
  • Grants & Funding  
    • Issuance of PAR-20-043
    • Frequently Asked Questions
    • PRMS and CPDM Guidance
    • Peer Review Process
    Skip to content
    • Policy on Peer Review of DMSP
    • DSMP Review by NCI Staff
    • ICD 10
    • Data Guide v3.1
    • eData v3.1.1
    • eData Templates
    • RPPR Instructions
  • News & Events  
    • OCC Announcements  
  • Policies & Resources  
    • Peer Reviev Funding Systems
    • Cancer Center Identity Badges
    • CTSA
    • Skip to content
    • External Links:
    • NIH RePORT
    • The Cancer Control Planet
    • NCI Fact Book
    • Office of Extramural Research
    • PHS 2590
    • SF 424
    • The Cancer Control Planet
    • External Website Policy
  • About Us  
    • Meet Our Team
    • View Our History
    • Contact Us
    • Skip to content
    • Site Map
    • Keyboard Shortcuts
PRMSandCPDMGuidance

 PRMS and CPDM Guidance

Updated November 03, 2014


  • Home
  • Grants & Funding
  • PRMS and CPDM Guidance

Guidance Regarding the Protocol Review and Monitoring System and the Clinical Protocol and Data Management Components of the CCSG


Question: Could you provide some guidance regarding the definition of, requirement for, and support of ‘auditing’ within the Protocol Review and Monitoring System (PRMS) and/or the Clinical Protocol and Data Management (i.e., clinical trials office or CPDM) component of the CCSG?

Answer: As per CCSG guidance, auditing is not a function of the PRMS, which is focused on scientific review, prioritization, and monitoring. The PRMS is responsible for oversight of the scientific quality of studies approved, the monitoring of over- and under-accrual (as relevant to the study type), and the continuing scientific relevance of active studies.

Data auditing for quality control purposes is the function of the CPDM. The systematic checking of individual research subject files for accuracy of records and for meeting the conditions of the study is an expected and CCSG-supportable role for CPDM staff. Reviewers will evaluate the merit of the applicant’s quality control system, making a judgment on the description of the quality control procedures, but they will not do audits of individual patient/subject files. Quality control could be internal or external (e.g. Theradex), for example and reviewers should evaluate the appropriateness of the method.

Safety auditing is a Data and Safety Monitoring (DSM) function, which is now a sub-section of the CPDM component. DSM and PRMS activities should be carried out by separate bodies, appropriate to the type, complexity and risks associated with the study. Although there may be minor overlap of membership between the PRMS and DSM, the functions are distinct for each body.

In addition to other CCSG review criteria relevant to the PRMS, CPDM, and DSM, reviewers should particularly ensure that functions of the PRMS and the DSM - one focusing on science, one on safety – are distinct and separate.

PDF Version

Home|Contact Us|Accessibility|FOIA

U.S. Department of Health and Human Services|National Institutes of Health|National Cancer Institute|USA.gov

NIH…Turning Discovery Into Health®

2021 - The Office Of Cancer Centers at NCI